(Q36696097)

15 August 2017

1 reference

title

The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia (English)

1 reference

15 August 2017

0 references

1 reference

3

Jürgen Gallinat

0 references

Anissa Abi-Dargham

series ordinal

5

object named as

Anissa Abi-Dargham

1 reference

15 August 2017

1

John H Krystal

1 reference

15 August 2017

8

Godfrey Pearlson

1 reference

15 August 2017

7

Andreas Heinz

1 reference

15 August 2017

D Cyril D'Souza

2

1 reference

15 August 2017

Naomi Driesen

series ordinal

4

1 reference

15 August 2017

Ismene Petrakis

series ordinal

6

1 reference

15 August 2017

publication date

1 December 2006

1 reference

15 August 2017

published in

Neurotoxicity Research

1 reference

15 August 2017

volume

10

1 reference

15 August 2017

issue

3-4

1 reference

15 August 2017

page(s)

235-252

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03033360

15 August 2017

exact match

0 references

cites work

Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil.

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

The New York High-Risk Project. Prevalence and comorbidity of axis I disorders in offspring of schizophrenic parents at 25-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Determinants of medication compliance in schizophrenia: empirical and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Anhedonia, self-experience in schizophrenia, and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

An independent analysis of the copenhagen sample of the Danish adoption study of schizophrenia. I. The relationship between anxiety disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. IV. The relationship between major depressive disorder and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Expectations and motives for substance use in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Meta-analysis of subjective sensitivity to alcohol in sons of alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Low level of response to alcohol as a predictor of future alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

An 8-year follow-up of 450 sons of alcoholic and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Decreases in dopamine receptors but not in dopamine transporters in alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033360

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

12 December 2020

Psychiatric illness in first-degree relatives of patients with paranoid psychosis, schizophrenia and medical illness.

1 reference

12 December 2020

Microdialysis of dopamine in the nucleus accumbens of alcohol-preferring (P) rats during anticipation and operant self-administration of ethanol

1 reference

12 December 2020

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms

1 reference

12 December 2020

Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward?

1 reference

12 December 2020

Smoking and schizophrenia: abnormal nicotinic receptor expression

1 reference

12 December 2020

Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input

1 reference

12 December 2020

Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London

1 reference

12 December 2020

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

1 reference

12 December 2020

Anticipation of increasing monetary reward selectively recruits nucleus accumbens

1 reference

12 December 2020

First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

1 reference

12 December 2020

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

1 reference

12 December 2020

Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems.

1 reference

12 December 2020

Nicotine and familial vulnerability to schizophrenia: a discordant twin study

1 reference

12 December 2020

6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography

1 reference

12 December 2020

1 reference

12 December 2020

Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers

1 reference

12 December 2020

Trauma, PTSD, and the course of severe mental illness: an interactive model

1 reference

12 December 2020

Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex

1 reference

12 December 2020

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

12 December 2020

Predictive reward signal of dopamine neurons

1 reference

12 December 2020

Dissociation of reward anticipation and outcome with event-related fMRI.

1 reference

12 December 2020

Psychopathology risk transmission in children of parents with substance use disorders

1 reference

12 December 2020

Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse.

1 reference

12 December 2020

A neurobiological basis for substance abuse comorbidity in schizophrenia

1 reference

12 December 2020

Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation.

1 reference

12 December 2020

Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7)

1 reference

12 December 2020

Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism

1 reference

12 December 2020

The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse

1 reference

12 December 2020

Non-psychotic disorders in the families of process schizophrenics

1 reference

12 December 2020

Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies

1 reference

12 December 2020

Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task

1 reference

12 December 2020

A twin study of individuals with both schizophrenia and alcoholism

1 reference

12 December 2020

Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia

1 reference

12 December 2020

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 reference

12 December 2020

Relationship of family history, antisocial personality disorder and personality traits in young men at risk for alcoholism

1 reference

12 December 2020

Substance misuse in patients with schizophrenia: epidemiology and management

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Neuropsychological probes of fronto-limbic system dysfunction in schizophrenia. Olfactory identification and Wisconsin Card Sorting performance.

1 reference

12 December 2020

[Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders]

1 reference

12 December 2020

Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving

1 reference

12 December 2020

Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers

1 reference

12 December 2020

A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI.

1 reference

12 December 2020

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

1 reference

12 December 2020

Olfactory deficits in schizophrenia

1 reference

12 December 2020

Substance abuse in schizophrenia: service utilization and costs

1 reference

12 December 2020

[Psychopathological correlates of dopaminergic dysfunction in alcoholic and schizophrenic patients].

1 reference

12 December 2020

A two-process theory of schizophrenia: evidence from studies in post-mortem brain

1 reference

12 December 2020

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

1 reference

12 December 2020

Regional brain metabolic response to lorazepam in subjects at risk for alcoholism.

1 reference

12 December 2020

Nicotine use in schizophrenia and disinhibition

1 reference

12 December 2020

Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia

1 reference

12 December 2020

Amphetamine modulates human incentive processing

1 reference

12 December 2020

Sociopathy, gender, and treatment outcome among outpatient substance abusers.

1 reference

12 December 2020

Phencyclidine interferes with the hippocampal gating of nucleus accumbens neuronal activity in vivo

1 reference

12 December 2020

Family history of alcoholism in schizophrenia

1 reference

12 December 2020

Implications of genetic epidemiology for the prevention of substance use disorders.

1 reference

12 December 2020

Amygdalar recruitment during anticipation of monetary rewards: an event-related fMRI study.

1 reference

12 December 2020

Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers.

1 reference

12 December 2020

Heroin use as an attempt to cope: clinical observations

1 reference

12 December 2020

Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists.

1 reference

12 December 2020

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

1 reference

12 December 2020

Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: results from a large cohort

1 reference

12 December 2020

Operant conditioning and the orbitofrontal cortex in schizophrenic patients: unexpected evidence for intact functioning.

1 reference

12 December 2020

Neurobehavioural mechanisms of reward and motivation.

1 reference

12 December 2020

[Consumption patterns and motivation for use of addictive drugs in schizophrenic patients]

1 reference

12 December 2020

Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions

1 reference

12 December 2020

Discrete coding of reward probability and uncertainty by dopamine neurons.

1 reference

12 December 2020

Drug-use behavior and correlates in people with schizophrenia

1 reference

12 December 2020

Traumatic life events and PTSD among women with substance use disorders and schizophrenia.

1 reference

12 December 2020

Addiction changes orbitofrontal gyrus function: involvement in response inhibition

1 reference

12 December 2020

Affect recognition in deficit syndrome schizophrenia.

1 reference

12 December 2020

Gender differences in lifetime psychiatric disorders between sons and daughters of alcoholic mothers: a pilot study.

1 reference

12 December 2020

Emotion, decision making and the orbitofrontal cortex

1 reference

12 December 2020

Quality of life and temperament factors in schizophrenia: comparative study of patients, their siblings and controls.

1 reference

12 December 2020

Schizophrenia and depression: challenging the paradigm of two separate diseases--a controlled study of schizophrenia, depression and healthy controls

1 reference

12 December 2020

Glutamate receptor expression in schizophrenic brain

1 reference

12 December 2020

Brain sabotages sobriety, right on cue: Pavlov's progeny provide pictures of alcoholism.

1 reference

12 December 2020

Pharmacotherapy for schizophrenia and co-occurring substance use disorders

1 reference

12 December 2020

Presynaptic dopaminergic function in the striatum of schizophrenic patients.

1 reference

12 December 2020

1 reference

12 December 2020

Relationships between symptoms of schizophrenia and substance abuse

1 reference

12 December 2020

Clinical heterogeneity in schizophrenia and the pattern of psychopathology in relatives: results from an epidemiologically based family study

1 reference

12 December 2020

Genetic differences in alcohol sensitivity and the inheritance of alcoholism risk

1 reference

12 December 2020

Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study

1 reference

12 December 2020

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

12 December 2020

Dissociable effects of cingulate and medial frontal cortex lesions on stimulus-reward learning using a novel Pavlovian autoshaping procedure for the rat: implications for the neurobiology of emotion.

1 reference

12 December 2020

Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action

1 reference

12 December 2020

Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes

1 reference

12 December 2020

Conduct disorder, antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders.

1 reference

12 December 2020

A family study of schizophrenic and normal control probands: implications for the spectrum concept of schizophrenia.

1 reference

12 December 2020

Deficit and nondeficit forms of schizophrenia: the concept

1 reference

12 December 2020

Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake

1 reference

12 December 2020

Effects of gender and family history of alcohol dependence on a behavioral task of impulsivity in healthy subjects

1 reference

12 December 2020

Impaired preferences for praise in schizophrenic adolescents.

1 reference

12 December 2020

Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients

1 reference

12 December 2020

Increased dopamine transmission in schizophrenia: relationship to illness phases

1 reference

12 December 2020

Alcohol and drug abusers subtyped by antisocial personality and primary or secondary depressive disorder

1 reference

12 December 2020

Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia

1 reference

12 December 2020

Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight

1 reference

12 December 2020

Motivation and performance in schizophrenia.

1 reference

12 December 2020

Effects of cocaine on hospital course in schizophrenia.

1 reference

12 December 2020

Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

1 reference

12 December 2020

Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.

1 reference

12 December 2020

Patterns of substance abuse in schizophrenia: nature and significance

1 reference

12 December 2020

Substance-abusing schizophrenics: do they self-medicate?

1 reference

12 December 2020

Elevated dopa decarboxylase activity in living brain of patients with psychosis

1 reference

12 December 2020

Changes in brain activation associated with reward processing in smokers and nonsmokers. A positron emission tomography study

1 reference

12 December 2020

Trauma and posttraumatic stress disorder in people with schizophrenia

1 reference

12 December 2020

Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum

1 reference

12 December 2020

Adaptive coding of reward value by dopamine neurons

1 reference

12 December 2020

A family study of alcohol dependence: coaggregation of multiple disorders in relatives of alcohol-dependent probands

1 reference

12 December 2020

Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia.

1 reference

12 December 2020

Is Substance Abuse in Schizophrenia Related to Impulsivity, Sensation Seeking, or Anhedonia?

1 reference

12 December 2020

Psychosocial aspects of substance abuse by clients with severe mental illness

1 reference

12 December 2020

The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies

1 reference

12 December 2020

Effects of expectations for different reward magnitudes on neuronal activity in primate striatum.

1 reference

12 December 2020

Relationship of positive and negative symptoms to cocaine abuse in schizophrenia.

1 reference

12 December 2020

Effects of smoking abstinence on visuospatial working memory function in schizophrenia

1 reference

12 December 2020

Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders

1 reference

12 December 2020

Schizophrenia subdivided by the family history of affective disorder. A comparison of symptomatology and course of illness

1 reference

12 December 2020

Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia.

1 reference

12 December 2020

The risk for psychiatric illness in siblings of schizophrenics: the impact of psychotic and non-psychotic affective illness and alcoholism in parents

1 reference

12 December 2020

Discounting of delayed rewards in substance abusers: relationship to antisocial personality disorder.

1 reference

12 December 2020

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex

1 reference

12 December 2020

Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects

1 reference

12 December 2020

Pharmacophilia and pharmacophobia: determinants of patients' attitudes towards antipsychotic medication.

1 reference

12 December 2020

Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior.

1 reference

12 December 2020

Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms

1 reference

12 December 2020

Substance use disorders in schizophrenia: review, integration, and a proposed model

1 reference

12 December 2020

Naltrexone in the treatment of alcohol dependence

1 reference

12 December 2020

Nicotine effects on brain function and functional connectivity in schizophrenia

1 reference

12 December 2020

A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice

1 reference

12 December 2020

Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors.

1 reference

12 December 2020

Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia

1 reference

12 December 2020

Stimulus differentiation by schizophrenic and normal subjects under conditions of reward and punishment.

1 reference

12 December 2020

NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy

1 reference

12 December 2020

Incentive-elicited brain activation in adolescents: similarities and differences from young adults.

1 reference

12 December 2020

Delayed mesolimbic system alteration in a developmental animal model of schizophrenia.

1 reference

12 December 2020

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033360

1 reference

15 August 2017

1 reference